nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmethylphenidate—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Dexmethylphenidate—Alopecia—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Dexmethylphenidate—Confusional state—Bleomycin—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Dexmethylphenidate—Vision blurred—Carmustine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Dexmethylphenidate—Tremor—Carmustine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Dexmethylphenidate—Oedema—Bleomycin—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Dexmethylphenidate—Erythema—Mitoxantrone—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Dexmethylphenidate—Infection—Bleomycin—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Dexmethylphenidate—Anaemia—Carmustine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Dexmethylphenidate—Back pain—Vincristine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Dexmethylphenidate—Vomiting—Teniposide—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Dexmethylphenidate—Agitation—Carmustine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Dexmethylphenidate—Asthenia—Fludarabine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Dexmethylphenidate—Rash—Teniposide—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Dexmethylphenidate—Dermatitis—Teniposide—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Dexmethylphenidate—Headache—Teniposide—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Dexmethylphenidate—Pruritus—Fludarabine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Dexmethylphenidate—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Dexmethylphenidate—Back pain—Mitoxantrone—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Dexmethylphenidate—Leukopenia—Carmustine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Dexmethylphenidate—Anorexia—Bleomycin—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Dexmethylphenidate—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Dexmethylphenidate—Anaemia—Vincristine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Dexmethylphenidate—Agitation—Vincristine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Dexmethylphenidate—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Dexmethylphenidate—Photosensitivity—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Fludarabine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Dexmethylphenidate—Convulsion—Carmustine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Dexmethylphenidate—Hypertension—Carmustine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Dexmethylphenidate—Nausea—Teniposide—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Dexmethylphenidate—Anaemia—Mitoxantrone—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Dexmethylphenidate—Vertigo—Vincristine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Dexmethylphenidate—Leukopenia—Vincristine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Dexmethylphenidate—Chest pain—Carmustine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Dexmethylphenidate—Myalgia—Carmustine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Dexmethylphenidate—Anxiety—Carmustine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Bleomycin—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Dexmethylphenidate—Malaise—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Bleomycin—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Dexmethylphenidate—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Dexmethylphenidate—Convulsion—Vincristine—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Dexmethylphenidate—Hypertension—Vincristine—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Dexmethylphenidate—Confusional state—Carmustine—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Dexmethylphenidate—Oedema—Carmustine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Dexmethylphenidate—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Bleomycin—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Dexmethylphenidate—Myalgia—Vincristine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Dexmethylphenidate—Visual disturbance—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Dexmethylphenidate—Cough—Mitoxantrone—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Dexmethylphenidate—Infection—Carmustine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Dexmethylphenidate—Vomiting—Fludarabine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Dexmethylphenidate—Convulsion—Mitoxantrone—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Dexmethylphenidate—Rash—Fludarabine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Dexmethylphenidate—Dermatitis—Fludarabine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Dexmethylphenidate—Hypertension—Mitoxantrone—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Dexmethylphenidate—Pain—Bleomycin—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Dexmethylphenidate—Headache—Fludarabine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Dexmethylphenidate—Tachycardia—Carmustine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Dexmethylphenidate—Chest pain—Mitoxantrone—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Dexmethylphenidate—Myalgia—Mitoxantrone—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Dexmethylphenidate—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Dexmethylphenidate—Anxiety—Mitoxantrone—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Dexmethylphenidate—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Dexmethylphenidate—Lethargy—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Dexmethylphenidate—Discomfort—Mitoxantrone—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Dexmethylphenidate—Oedema—Vincristine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Dexmethylphenidate—Anorexia—Carmustine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Dexmethylphenidate—Infection—Vincristine—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Dexmethylphenidate—Confusional state—Mitoxantrone—lymphatic system cancer	0.001	0.001	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Vincristine—lymphatic system cancer	0.001	0.001	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Vincristine—lymphatic system cancer	0.001	0.001	CcSEcCtD
Dexmethylphenidate—Oedema—Mitoxantrone—lymphatic system cancer	0.000995	0.000995	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000995	0.000995	CcSEcCtD
Dexmethylphenidate—Nausea—Fludarabine—lymphatic system cancer	0.000993	0.000993	CcSEcCtD
Dexmethylphenidate—Infection—Mitoxantrone—lymphatic system cancer	0.000988	0.000988	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000987	0.000987	CcSEcCtD
Dexmethylphenidate—Shock—Mitoxantrone—lymphatic system cancer	0.000979	0.000979	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000975	0.000975	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000974	0.000974	CcSEcCtD
Dexmethylphenidate—Urticaria—Bleomycin—lymphatic system cancer	0.000974	0.000974	CcSEcCtD
Dexmethylphenidate—Anorexia—Vincristine—lymphatic system cancer	0.000974	0.000974	CcSEcCtD
Dexmethylphenidate—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000971	0.000971	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Bleomycin—lymphatic system cancer	0.000969	0.000969	CcSEcCtD
Dexmethylphenidate—Insomnia—Carmustine—lymphatic system cancer	0.000968	0.000968	CcSEcCtD
Dexmethylphenidate—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000966	0.000966	CcSEcCtD
Dexmethylphenidate—Irritability—Methotrexate—lymphatic system cancer	0.000962	0.000962	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000962	0.000962	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Carmustine—lymphatic system cancer	0.000961	0.000961	CcSEcCtD
Dexmethylphenidate—Mood swings—Methotrexate—lymphatic system cancer	0.000955	0.000955	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Carmustine—lymphatic system cancer	0.000954	0.000954	CcSEcCtD
Dexmethylphenidate—Somnolence—Carmustine—lymphatic system cancer	0.000951	0.000951	CcSEcCtD
Dexmethylphenidate—Anorexia—Mitoxantrone—lymphatic system cancer	0.000948	0.000948	CcSEcCtD
Dexmethylphenidate—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000931	0.000931	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000931	0.000931	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Carmustine—lymphatic system cancer	0.00093	0.00093	CcSEcCtD
Dexmethylphenidate—Insomnia—Vincristine—lymphatic system cancer	0.000924	0.000924	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000924	0.000924	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Vincristine—lymphatic system cancer	0.000917	0.000917	CcSEcCtD
Dexmethylphenidate—Constipation—Carmustine—lymphatic system cancer	0.000915	0.000915	CcSEcCtD
Dexmethylphenidate—Pain—Carmustine—lymphatic system cancer	0.000915	0.000915	CcSEcCtD
Dexmethylphenidate—Breast disorder—Methotrexate—lymphatic system cancer	0.000911	0.000911	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000906	0.000906	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000903	0.000903	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000893	0.000893	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Vincristine—lymphatic system cancer	0.000888	0.000888	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000887	0.000887	CcSEcCtD
Dexmethylphenidate—Somnolence—Mitoxantrone—lymphatic system cancer	0.000884	0.000884	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000882	0.000882	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Carmustine—lymphatic system cancer	0.000882	0.000882	CcSEcCtD
Dexmethylphenidate—Fatigue—Vincristine—lymphatic system cancer	0.000881	0.000881	CcSEcCtD
Dexmethylphenidate—Asthenia—Bleomycin—lymphatic system cancer	0.00088	0.00088	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000876	0.000876	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000875	0.000875	CcSEcCtD
Dexmethylphenidate—Constipation—Vincristine—lymphatic system cancer	0.000873	0.000873	CcSEcCtD
Dexmethylphenidate—Pain—Vincristine—lymphatic system cancer	0.000873	0.000873	CcSEcCtD
Dexmethylphenidate—Asthma—Methotrexate—lymphatic system cancer	0.000872	0.000872	CcSEcCtD
Dexmethylphenidate—Pruritus—Bleomycin—lymphatic system cancer	0.000867	0.000867	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000865	0.000865	CcSEcCtD
Dexmethylphenidate—Fatigue—Mitoxantrone—lymphatic system cancer	0.000858	0.000858	CcSEcCtD
Dexmethylphenidate—Pancreatitis—Methotrexate—lymphatic system cancer	0.000855	0.000855	CcSEcCtD
Dexmethylphenidate—Pain—Mitoxantrone—lymphatic system cancer	0.000851	0.000851	CcSEcCtD
Dexmethylphenidate—Constipation—Mitoxantrone—lymphatic system cancer	0.000851	0.000851	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Carmustine—lymphatic system cancer	0.000846	0.000846	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Carmustine—lymphatic system cancer	0.000846	0.000846	CcSEcCtD
Dexmethylphenidate—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000836	0.000836	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000835	0.000835	CcSEcCtD
Dexmethylphenidate—Pancytopenia—Methotrexate—lymphatic system cancer	0.000828	0.000828	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00082	0.00082	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000813	0.000813	CcSEcCtD
Dexmethylphenidate—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00081	0.00081	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Vincristine—lymphatic system cancer	0.000807	0.000807	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Vincristine—lymphatic system cancer	0.000807	0.000807	CcSEcCtD
Dexmethylphenidate—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000803	0.000803	CcSEcCtD
Dexmethylphenidate—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000796	0.000796	CcSEcCtD
Dexmethylphenidate—Urticaria—Mitoxantrone—lymphatic system cancer	0.00079	0.00079	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Carmustine—lymphatic system cancer	0.000788	0.000788	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000786	0.000786	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000786	0.000786	CcSEcCtD
Dexmethylphenidate—Pneumonia—Methotrexate—lymphatic system cancer	0.000782	0.000782	CcSEcCtD
Dexmethylphenidate—Vomiting—Bleomycin—lymphatic system cancer	0.000779	0.000779	CcSEcCtD
Dexmethylphenidate—Infestation NOS—Methotrexate—lymphatic system cancer	0.000777	0.000777	CcSEcCtD
Dexmethylphenidate—Infestation—Methotrexate—lymphatic system cancer	0.000777	0.000777	CcSEcCtD
Dexmethylphenidate—Drowsiness—Methotrexate—lymphatic system cancer	0.000777	0.000777	CcSEcCtD
Dexmethylphenidate—Depression—Methotrexate—lymphatic system cancer	0.000775	0.000775	CcSEcCtD
Dexmethylphenidate—Rash—Bleomycin—lymphatic system cancer	0.000773	0.000773	CcSEcCtD
Dexmethylphenidate—Dermatitis—Bleomycin—lymphatic system cancer	0.000772	0.000772	CcSEcCtD
Dexmethylphenidate—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00077	0.00077	CcSEcCtD
Dexmethylphenidate—Asthenia—Carmustine—lymphatic system cancer	0.000768	0.000768	CcSEcCtD
Dexmethylphenidate—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000755	0.000755	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Vincristine—lymphatic system cancer	0.000753	0.000753	CcSEcCtD
Dexmethylphenidate—Sweating—Methotrexate—lymphatic system cancer	0.000745	0.000745	CcSEcCtD
Dexmethylphenidate—Haematuria—Methotrexate—lymphatic system cancer	0.000741	0.000741	CcSEcCtD
Dexmethylphenidate—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000735	0.000735	CcSEcCtD
Dexmethylphenidate—Epistaxis—Methotrexate—lymphatic system cancer	0.000733	0.000733	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000733	0.000733	CcSEcCtD
Dexmethylphenidate—Asthenia—Vincristine—lymphatic system cancer	0.000733	0.000733	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Carmustine—lymphatic system cancer	0.000732	0.000732	CcSEcCtD
Dexmethylphenidate—Nausea—Bleomycin—lymphatic system cancer	0.000728	0.000728	CcSEcCtD
Dexmethylphenidate—Asthenia—Mitoxantrone—lymphatic system cancer	0.000714	0.000714	CcSEcCtD
Dexmethylphenidate—Dizziness—Carmustine—lymphatic system cancer	0.000708	0.000708	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Methotrexate—lymphatic system cancer	0.000701	0.000701	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Vincristine—lymphatic system cancer	0.000699	0.000699	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Methotrexate—lymphatic system cancer	0.000698	0.000698	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Methotrexate—lymphatic system cancer	0.000692	0.000692	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000689	0.000689	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Methotrexate—lymphatic system cancer	0.000684	0.000684	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000681	0.000681	CcSEcCtD
Dexmethylphenidate—Vomiting—Carmustine—lymphatic system cancer	0.00068	0.00068	CcSEcCtD
Dexmethylphenidate—Dizziness—Vincristine—lymphatic system cancer	0.000675	0.000675	CcSEcCtD
Dexmethylphenidate—Rash—Carmustine—lymphatic system cancer	0.000675	0.000675	CcSEcCtD
Dexmethylphenidate—Dermatitis—Carmustine—lymphatic system cancer	0.000674	0.000674	CcSEcCtD
Dexmethylphenidate—Visual impairment—Methotrexate—lymphatic system cancer	0.000672	0.000672	CcSEcCtD
Dexmethylphenidate—Headache—Carmustine—lymphatic system cancer	0.00067	0.00067	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00066	0.00066	CcSEcCtD
Dexmethylphenidate—Eye disorder—Methotrexate—lymphatic system cancer	0.000652	0.000652	CcSEcCtD
Dexmethylphenidate—Vomiting—Vincristine—lymphatic system cancer	0.000649	0.000649	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000647	0.000647	CcSEcCtD
Dexmethylphenidate—Rash—Vincristine—lymphatic system cancer	0.000644	0.000644	CcSEcCtD
Dexmethylphenidate—Dermatitis—Vincristine—lymphatic system cancer	0.000643	0.000643	CcSEcCtD
Dexmethylphenidate—Headache—Vincristine—lymphatic system cancer	0.00064	0.00064	CcSEcCtD
Dexmethylphenidate—Nausea—Carmustine—lymphatic system cancer	0.000636	0.000636	CcSEcCtD
Dexmethylphenidate—Angiopathy—Methotrexate—lymphatic system cancer	0.000633	0.000633	CcSEcCtD
Dexmethylphenidate—Vomiting—Mitoxantrone—lymphatic system cancer	0.000632	0.000632	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Methotrexate—lymphatic system cancer	0.00063	0.00063	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000629	0.000629	CcSEcCtD
Dexmethylphenidate—Rash—Mitoxantrone—lymphatic system cancer	0.000627	0.000627	CcSEcCtD
Dexmethylphenidate—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000627	0.000627	CcSEcCtD
Dexmethylphenidate—Chills—Methotrexate—lymphatic system cancer	0.000626	0.000626	CcSEcCtD
Dexmethylphenidate—Headache—Mitoxantrone—lymphatic system cancer	0.000623	0.000623	CcSEcCtD
Dexmethylphenidate—Alopecia—Methotrexate—lymphatic system cancer	0.000616	0.000616	CcSEcCtD
Dexmethylphenidate—Mental disorder—Methotrexate—lymphatic system cancer	0.000611	0.000611	CcSEcCtD
Dexmethylphenidate—Malnutrition—Methotrexate—lymphatic system cancer	0.000607	0.000607	CcSEcCtD
Dexmethylphenidate—Erythema—Methotrexate—lymphatic system cancer	0.000607	0.000607	CcSEcCtD
Dexmethylphenidate—Nausea—Vincristine—lymphatic system cancer	0.000607	0.000607	CcSEcCtD
Dexmethylphenidate—Nausea—Mitoxantrone—lymphatic system cancer	0.000591	0.000591	CcSEcCtD
Dexmethylphenidate—Back pain—Methotrexate—lymphatic system cancer	0.000587	0.000587	CcSEcCtD
Dexmethylphenidate—Vision blurred—Methotrexate—lymphatic system cancer	0.000572	0.000572	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000563	0.000563	CcSEcCtD
Dexmethylphenidate—Anaemia—Methotrexate—lymphatic system cancer	0.000561	0.000561	CcSEcCtD
Dexmethylphenidate—Malaise—Methotrexate—lymphatic system cancer	0.000548	0.000548	CcSEcCtD
Dexmethylphenidate—Vertigo—Methotrexate—lymphatic system cancer	0.000546	0.000546	CcSEcCtD
Dexmethylphenidate—Leukopenia—Methotrexate—lymphatic system cancer	0.000544	0.000544	CcSEcCtD
Dexmethylphenidate—Cough—Methotrexate—lymphatic system cancer	0.00053	0.00053	CcSEcCtD
Dexmethylphenidate—Convulsion—Methotrexate—lymphatic system cancer	0.000526	0.000526	CcSEcCtD
Dexmethylphenidate—Arthralgia—Methotrexate—lymphatic system cancer	0.000517	0.000517	CcSEcCtD
Dexmethylphenidate—Chest pain—Methotrexate—lymphatic system cancer	0.000517	0.000517	CcSEcCtD
Dexmethylphenidate—Myalgia—Methotrexate—lymphatic system cancer	0.000517	0.000517	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000513	0.000513	CcSEcCtD
Dexmethylphenidate—Discomfort—Methotrexate—lymphatic system cancer	0.000511	0.000511	CcSEcCtD
Dexmethylphenidate—Confusional state—Methotrexate—lymphatic system cancer	0.0005	0.0005	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000496	0.000496	CcSEcCtD
Dexmethylphenidate—Infection—Methotrexate—lymphatic system cancer	0.000492	0.000492	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000486	0.000486	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000485	0.000485	CcSEcCtD
Dexmethylphenidate—Skin disorder—Methotrexate—lymphatic system cancer	0.000481	0.000481	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000479	0.000479	CcSEcCtD
Dexmethylphenidate—Anorexia—Methotrexate—lymphatic system cancer	0.000472	0.000472	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000452	0.000452	CcSEcCtD
Dexmethylphenidate—Insomnia—Methotrexate—lymphatic system cancer	0.000448	0.000448	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Methotrexate—lymphatic system cancer	0.000445	0.000445	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Methotrexate—lymphatic system cancer	0.000442	0.000442	CcSEcCtD
Dexmethylphenidate—Somnolence—Methotrexate—lymphatic system cancer	0.000441	0.000441	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Methotrexate—lymphatic system cancer	0.000436	0.000436	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Methotrexate—lymphatic system cancer	0.000431	0.000431	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000428	0.000428	CcSEcCtD
Dexmethylphenidate—Fatigue—Methotrexate—lymphatic system cancer	0.000427	0.000427	CcSEcCtD
Dexmethylphenidate—Pain—Methotrexate—lymphatic system cancer	0.000424	0.000424	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000408	0.000408	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000405	0.000405	CcSEcCtD
Dexmethylphenidate—Urticaria—Methotrexate—lymphatic system cancer	0.000394	0.000394	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Methotrexate—lymphatic system cancer	0.000392	0.000392	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Methotrexate—lymphatic system cancer	0.000392	0.000392	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000365	0.000365	CcSEcCtD
Dexmethylphenidate—Asthenia—Methotrexate—lymphatic system cancer	0.000356	0.000356	CcSEcCtD
Dexmethylphenidate—Pruritus—Methotrexate—lymphatic system cancer	0.000351	0.000351	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Methotrexate—lymphatic system cancer	0.000339	0.000339	CcSEcCtD
Dexmethylphenidate—Dizziness—Methotrexate—lymphatic system cancer	0.000328	0.000328	CcSEcCtD
Dexmethylphenidate—Vomiting—Methotrexate—lymphatic system cancer	0.000315	0.000315	CcSEcCtD
Dexmethylphenidate—Rash—Methotrexate—lymphatic system cancer	0.000312	0.000312	CcSEcCtD
Dexmethylphenidate—Dermatitis—Methotrexate—lymphatic system cancer	0.000312	0.000312	CcSEcCtD
Dexmethylphenidate—Headache—Methotrexate—lymphatic system cancer	0.00031	0.00031	CcSEcCtD
Dexmethylphenidate—Nausea—Methotrexate—lymphatic system cancer	0.000294	0.000294	CcSEcCtD
